NFL Declines to Penalize Eagles for Jalen Hurts' Blood Clots Management

The Philadelphia Eagles will not face disciplinary action regarding their handling of quarterback Jalen Hurts' blood clot situation, according to a source familiar with the matter who spoke to the Associated Press on Tuesday. The discussions between the league and the team are to remain confidential.

In a statement released Tuesday, the NFL confirmed that league officials had been in contact with Eagles medical staff and the Cleveland Clinic in London throughout Hurts' treatment. The NFL emphasized that its chief medical officer, Dr. Allen Sills, ensures medical resources with leading providers in international markets with approval from the NFL Players Association. Medical care for players is coordinated between club medical staff and independent doctors.

Dr. Sills and other officials were expected to speak to reporters at the league’s annual fall meeting in New York on Tuesday.

Hurts is currently on injured reserve and is anticipated to miss the remainder of the season due to a blood clot in his left calf that traveled to his lungs. The Eagles and his agent, Nicole Lynn, announced Monday that Hurts has been diagnosed with deep vein thrombosis and bilateral pulmonary emboli.

His treatment includes blood thinners, and he is prohibited from participating in any football activities until he is no longer taking them.

Hurts played against Jacksonville in London on October 11, three days after notifying medical staff of his injury during practice. Initially, specialists in London diagnosed him with a superficial vein thrombosis in his left calf.